Sviridov Dmitri, Netea Mihai G, Bukrinsky Michael I
Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.
J Clin Invest. 2025 Sep 2;135(17). doi: 10.1172/JCI192469.
Trained immunity (TRIM) is a form of long-lasting functional reprogramming of innate immune cells and their progenitors that enhances responsiveness to subsequent stimuli. Although first characterized in myeloid cells, TRIM was recently extended to nonmyeloid cell types, including endothelial and glial cells, which also exhibit stimulus-driven, memory-like behavior. While initially recognized as a protective mechanism, particularly in the context of vaccines and acute infections, TRIM can also become maladaptive, promoting chronic inflammation, immune dysfunction, and disease. This Review focuses on virus-induced TRIM while also addressing microbial, metabolic, and endogenous inducers. We examine key ligands and receptors that initiate TRIM and dissect the associated signaling and epigenetic pathways. Importantly, we argue that maladaptive TRIM arises not from a specific ligand, receptor, or molecular event, but from contextual factors such as stimulus persistence, dose, tissue microenvironment, and preexisting inflammation. The nature of the secondary challenge also shapes whether a trained response is adaptive or maladaptive. We further discuss TRIM induction in the bone marrow, involvement of both myeloid and nonmyeloid cells, and the role of lipid rafts in sustaining TRIM. We review maladaptive TRIM's potential contribution to systemic diseases, such as atherosclerosis, diabetes, sepsis, cancer, and autoimmunity, along with its influence on viral vaccine responses. Finally, we outline potential strategies to redirect maladaptive TRIM and propose key outstanding questions for future research.
训练有素的免疫(TRIM)是先天性免疫细胞及其祖细胞的一种持久性功能重编程形式,可增强对后续刺激的反应性。尽管TRIM最初是在髓系细胞中被发现的,但最近它已扩展到非髓系细胞类型,包括内皮细胞和神经胶质细胞,这些细胞也表现出刺激驱动的、类似记忆的行为。虽然TRIM最初被认为是一种保护机制,特别是在疫苗和急性感染的背景下,但它也可能变得适应不良,从而促进慢性炎症、免疫功能障碍和疾病。本综述重点关注病毒诱导的TRIM,同时也涉及微生物、代谢和内源性诱导剂。我们研究启动TRIM的关键配体和受体,并剖析相关的信号传导和表观遗传途径。重要的是,我们认为适应不良的TRIM并非源于特定的配体、受体或分子事件,而是源于刺激持续性、剂量、组织微环境和既往炎症等背景因素。二次挑战的性质也决定了训练有素的反应是适应性的还是适应不良的。我们进一步讨论了骨髓中的TRIM诱导、髓系和非髓系细胞的参与以及脂筏在维持TRIM中的作用。我们综述了适应不良的TRIM对全身性疾病(如动脉粥样硬化、糖尿病、脓毒症、癌症和自身免疫性疾病)的潜在影响,以及它对病毒疫苗反应的影响。最后,我们概述了纠正适应不良的TRIM的潜在策略,并提出了未来研究的关键悬而未决的问题。